Source: Annual Congress 2010 - Airway smooth muscle cells
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Keglowich, E. Kyriakakis, M. Philippova, T. J. Resink, M. Tamm, M. Roth, P. Borger (Switzerland). A novel strategy to counteract airway wall remodelling in asthma: Blocking the neo-vascularisation of the lamina propria. Eur Respir J 2010; 36: Suppl. 54, 2378

Member's Comments

No comment yet.

Related content which might interest you: A novel strategy to counteract airway wall remodelling in asthma: blocking the neo-vascularisation of the lamina propria Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Novel concepts in airway inflammation and remodelling in asthma Source: Eur Respir J 2015; 46: 1796-1804 Year: 2015 Corticosteroids prevent airway remodeling in a mouse model of chronic asthma through TGF-β signaling Source: Eur Respir J 2006; 28: Suppl. 50, 225s Year: 2006 Identifying a therapeutic target for ablating new blood vessel formation in patients with asthma Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Targeting ASK1 in preventing airway smooth muscle growth: Implications for airway remodeling in COPD Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 A new series on airway remodelling Source: Eur Respir J 2007; 29: 231-232 Year: 2007 Continuous airway inflammation is related to the development of airway remodeling Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012 Basic mechanisms of development of airway structural changes in asthma Source: Eur Respir J 2007; 29: 379-389 Year: 2007 Are we ready to monitor inflammation and remodelling in asthma? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005 Inhibition of the alternative complement pathway abolishes the development of airway hyperresponsiveness (AHR) and inflammation Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004 Airway inflammatory mediators and airway wall remodelling in asthma Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 Role of remodelling in asthma Source: Annual Congress 2006 - PG15 - Remodelling and repair in lung disease Year: 2006 The GPx1-PTP1B-PP2A axis: A key determinant of airway inflammation and alveolar destruction Source: Annual Congress 2013 –Acute lung injury: novel clinical and experimental insights Year: 2013 Essential roles of q110 in IL13 in airway remodelling in bronchial asthma Source: Annual Congress 2009 - Airways remodelling Year: 2009 Tolerance repair for asthma treatment does not require airway remodelling Source: Eur Respir J 2006; 28: Suppl. 50, 591s Year: 2006 Role of apoptosis in airway smooth muscle remodeling in experimental asthma Source: Eur Respir J 2007; 30: Suppl. 51, 369s Year: 2007 Reduced airway distensibility, fixed airflow limitation and airway wall remodelling in asthma Source: Eur Respir J 2001; 18: Suppl. 33, 349s Year: 2001